The downregulation of DNAJA2 in islets and its inverse correlation with BMI in T2DM patients, along with its upregulation in adipocytes and hepatocytes in response to obesity and HSD, highlight a complex role of DNAJA2 in glucose metabolism and T2DM pathophysiology. The gene discussed is CHST3; the disease is obesity due to melanocortin 4 receptor deficiency.